Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

Mediation of most atypical effects by species homologs of the beta(3)-adrenoceptor

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Blin, N.
  • Nahmias, C.
  • Drumare, M. F.
  • Strosberg, Donny

publication date

  • July 1994

journal

  • British Journal of Pharmacology  Journal

abstract

  • 1. A wide panel of compounds acting on beta-adrenoceptors active either in mammalian heart or in rodent digestive tract and adipose tissues, were investigated for their effects on Chinese hamster ovary cells transfected with the human or murine beta 3-adrenoceptor gene. 2. The beta 3-agonists, bucindolol, CGP 12177A and pindolol exhibited the highest binding affinities; BRL 37344, LY 79771, ICI 201651 and SR 58611A presented high potencies in stimulating adenylyl cyclase; bupranolol appeared as the most efficient beta 3-antagonist. 3. This pharmacological analysis further established that the beta 3-adrenoceptor is the prototype of the adipose tissue atypical beta-adrenoceptor, since these receptors share a number of pharmacological properties which differ strikingly from those of beta 1- and beta 2-adrenoceptors: low affinities for conventional beta-adrenoceptor agonists and antagonists, high potencies for novel compounds active in adipose tissues, partial agonistic activities for several beta 1/beta 2-antagonists. 4. Although the pharmacological profiles of the human and murine beta 3-receptor were very similar, some quantitative or even qualitative differences were observed for particular compounds such as propranolol, which exhibited weak and partial agonistic effects at the human beta 3-receptors and antagonistic effects at the murine beta 3-receptors. These differences may result from key amino-acid substitutions between the human and the murine beta 3-receptor sequences, which may alter the binding site or signal processing. 5. Compounds active on atypical beta-sites of other tissues such as heart and digestive tract were also potent on the beta 3-adrenoceptor expressed in Chinese hamster ovary cells, suggesting that this receptor mediates most of the atypical properties described in various tissues, and that differences in ligand effects may result from tissue-related specificities.

subject areas

  • Adenylyl Cyclases
  • Adrenergic beta-Agonists
  • Adrenergic beta-Antagonists
  • Animals
  • CHO Cells
  • Colforsin
  • Cricetinae
  • Epinephrine
  • Humans
  • Iodocyanopindolol
  • Isoproterenol
  • Ligands
  • Mice
  • Norepinephrine
  • Pindolol
  • Radioligand Assay
  • Receptors, Adrenergic, beta
  • Receptors, Adrenergic, beta-3
  • Species Specificity
scroll to property group menus

Research

keywords

  • ADIPOSE TISSUES
  • ATYPICAL BETA-ADRENOCEPTORS
  • BETA(3)-ADRENOCEPTORS
  • INTESTINAL SMOOTH MUSCLE
  • PROPRANOLOL
  • SPECIES-SPECIFICITY
scroll to property group menus

Identity

PubMed Central ID

  • PMC1910199

International Standard Serial Number (ISSN)

  • 0007-1188

PubMed ID

  • 7921620
scroll to property group menus

Additional Document Info

start page

  • 911

end page

  • 919

volume

  • 112

issue

  • 3

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support